Literature DB >> 25339198

Expression pattern of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 genes in normal and cancer cervical tissues.

Andrej Nikoshkov1, Kristina Broliden2, Sanaz Attarha1, Vitali Sviatoha3, Ann-Cathrin Hellström4, Miriam Mints1, Sonia Andersson1.   

Abstract

Cervical cancer is the second most prevalent malignancy among women worldwide, and additional objective diagnostic markers for this disease are needed. Given the link between cancer development and alternative splicing, we aimed to analyze the splicing patterns of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 genes, which are associated with different cancers, in normal cervical tissue, preinvasive cervical lesions and invasive cervical tumors, to identify new objective diagnostic markers. Biopsies of normal cervical tissue, preinvasive cervical lesions and invasive cervical tumors, were subjected to rapid amplification of cDNA 3' ends (3' RACE) RT‑PCR. Resulting PCR products were analyzed on agarose gels, gel‑purified and sequenced. Normal cervical tissue, preinvasive cervical lesions and invasive cervical tumors contained one PCR product corresponding to full‑length PRDX2, RAB5A and RAB25 transcripts. All tissues contained two RAB1A‑specific PCR products corresponding to the full‑length transcript and one new alternatively spliced RAB1A transcript. Invasive cervical tumors contained one PCR product corresponding to the full‑length RAB1B transcript, while all normal cervical tissue and preinvasive cervical lesions contained both the full‑length RAB1B transcript and three new alternatively spliced RAB1B transcripts. Alternative splicing of the RAB1A transcript occurs in all cervical tissues, while alternative splicing of the RAB1B transcript occurs in normal cervical tissue and in preinvasive cervical lesions; not in invasive cervical tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339198     DOI: 10.3892/ijo.2014.2724

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

Review 1.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

2.  Proteomics analysis of proteins interacting with heat shock factor 1 in squamous cell carcinoma of the cervix.

Authors:  Lingli Zhang; Zhe Hu; Ying Zhang; Jinzhi Huang; Xuefen Yang; Jiafeng Wang
Journal:  Oncol Lett       Date:  2019-06-27       Impact factor: 2.967

3.  Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.

Authors:  Hong-Lin Jiang; He-Fen Sun; Shui-Ping Gao; Liang-Dong Li; Xin Hu; Jiong Wu; Wei Jin
Journal:  Oncotarget       Date:  2015-06-30

4.  Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.

Authors:  Xinxin Wang; Feng Liu; Xiaoyu Qin; Tinglei Huang; Bo Huang; Yanjie Zhang; Bin Jiang
Journal:  Aging (Albany NY)       Date:  2016-11-29       Impact factor: 5.682

5.  Rab1 interacts with GOLPH3 and controls Golgi structure and contractile ring constriction during cytokinesis in Drosophila melanogaster.

Authors:  Stefano Sechi; Anna Frappaolo; Roberta Fraschini; Luisa Capalbo; Marco Gottardo; Giorgio Belloni; David M Glover; Alan Wainman; Maria Grazia Giansanti
Journal:  Open Biol       Date:  2017-01       Impact factor: 6.411

6.  High expression of Rab25 contributes to malignant phenotypes and biochemical recurrence in patients with prostate cancer after radical prostatectomy.

Authors:  Chunhui Hu; Beibei Chen; Yibin Zhou; Yuxi Shan
Journal:  Cancer Cell Int       Date:  2017-04-11       Impact factor: 5.722

7.  Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.

Authors:  Xian-Zi Yang; Shu-Zhong Cui; Li-Si Zeng; Tian-Tian Cheng; Xiao-Xing Li; Jun Chi; Ren Wang; X F Steven Zheng; Hui-Yun Wang
Journal:  Aging (Albany NY)       Date:  2017-03-18       Impact factor: 5.682

8.  Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.

Authors:  Zhengwu Cheng; Xinyu Shao; Menglin Xu; Junfeng Wang; Xiaoyi Kuai; Liping Zhang; Jian Wu; Chunli Zhou; Jiading Mao
Journal:  Oncol Rep       Date:  2019-03-15       Impact factor: 3.906

9.  Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.

Authors:  Shreya Mitra; Lorenzo Federico; Wei Zhao; Jennifer Dennison; Tapasree Roy Sarkar; Fan Zhang; Vinita Takiar; Kwai W Cheng; Sendurai Mani; Ju Seog Lee; Gordon B Mills
Journal:  Oncotarget       Date:  2016-06-28

Review 10.  Rab1 in cell signaling, cancer and other diseases.

Authors:  X-Z Yang; X-X Li; Y-J Zhang; L Rodriguez-Rodriguez; M-Q Xiang; H-Y Wang; X F S Zheng
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.